Literature DB >> 2870818

In vivo toxicity of phenothiazines to cells of a transplantable tumor.

S Lehnert.   

Abstract

The toxicities of three phenothiazines, promazine, chlorpromazine, and trifluoperazine, towards cells of a mouse fibrosarcoma were quantified by means of an in vitro assay of clonogenic cell survival. For all three drugs cell kill was proportional to the amount of drug injected. Following injection of equimolar (0.2 mM/kg) amounts, cell survival was progressively reduced for a period of at least 48 h. On the basis of cell survival at 48 h after administration the ranking of the drugs for cytotoxicity, in ascending order, was trifluoperazine, chlorpromazine, promazine. A period of acute hypoxia prior to processing of the tumor did not enhance the toxicity of any of the drugs, and no change in the size of the hypoxic fraction of the tumor was seen 24 h after the injection of chlorpromazine. On this basis it was concluded that there was no evidence of enhanced toxicity of drugs for either chronically or acutely hypoxic tumor cells. A reduction in the number of clonogenic tumor cells per gram of tumor was largely the result of a fall in the number of viable cells recovered from the tumor. The plating efficiency of surviving cells remained constant or was only slightly depressed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2870818     DOI: 10.1007/bf00293990

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  21 in total

1.  An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions.

Authors:  J E Thomson; A M Rauth
Journal:  Radiat Res       Date:  1974-05       Impact factor: 2.841

2.  Pharmacological evaluation of clomacran, a new potent psychotropic agent.

Authors:  P J Fowler; C L Zirkle; E Macko; C Kaiser; H Sarau; D H Tedeschi
Journal:  Arzneimittelforschung       Date:  1977

3.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

Authors:  L H GRAY; A D CONGER; M EBERT; S HORNSEY; O C SCOTT
Journal:  Br J Radiol       Date:  1953-12       Impact factor: 3.039

4.  Hypoxic cytotoxicity of chlorpromazine and the modification of radiation response in E. coli B/r.

Authors:  M A Shenoy; B B Singh
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1978-12

5.  Oxygenation status of a transplantable tumor during fractionated radiation therapy.

Authors:  L M Van Putten; R F Kallman
Journal:  J Natl Cancer Inst       Date:  1968-03       Impact factor: 13.506

6.  Cytotoxic & radiosensitizing effects of chlorpromazine hydrochloride in sarcoma 180A.

Authors:  M A Shenoy; B B Singh
Journal:  Indian J Exp Biol       Date:  1980-08       Impact factor: 0.818

7.  Chlorpromazine distribution in hamsters and mice bearing transplantable melanoma.

Authors:  R G Fairchild; D Greenberg; K P Watts; S Packer; H L Atkins; P Som; S J Hannon; A B Brill; I Fand; W P McNally
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

8.  Induction and repair of X-ray damage in mammalian cell cultures treated with membrane-active drugs.

Authors:  U Bertsche
Journal:  Br J Cancer Suppl       Date:  1984

9.  Interaction of diethylaminoreserpine with cells of a transplantable tumour in vivo.

Authors:  S Lehnert
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

10.  Synergism of chlorpromazine and hyperthermia in two mouse solid tumours.

Authors:  K C George; B B Singh
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

View more
  2 in total

1.  Antitumor effects of ketoconazole and trifluoperazine in murine T-cell lymphomas.

Authors:  S Naftalovich; E Yefenof; Y Eilam
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Systematic discovery of multicomponent therapeutics.

Authors:  Alexis A Borisy; Peter J Elliott; Nicole W Hurst; Margaret S Lee; Joseph Lehar; E Roydon Price; George Serbedzija; Grant R Zimmermann; Michael A Foley; Brent R Stockwell; Curtis T Keith
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-10       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.